To test whether RUES2-CMs underwent inflammation, two inflammatory mediators—NFκB and STAT1—were chosen because NFκB and STAT1 are able to regulate PD-L1 expression in cancer cells [22]. This evidence concerns the gene STAT1 and cancer.